Pharmaceuticals

Congo receives 70,000 Ebola vaccine doses to fight outbreak

COVID Vaccines Safe for Pregnant Women Despite Recent Claims

FDA Approves First in Class Oral Drug for Advanced Multiple Myeloma

The FDA has approved a groundbreaking oral treatment for advanced multiple myeloma, introducing a new class of medicine for patients with the blood cancer.

DRC and WHO accelerate plans for Ebola vaccine trial

The Democratic Republic of the Congo and the World Health Organization are moving forward with plans to launch a Phase 3 clinical trial for Ebola vaccines amid ongoing public health efforts.

WHO Warns Trump Vaccine Plan Contradicts Decades of Evidence

The World Health Organization says Donald Trump's proposed changes to U.S. child vaccination policies ignore decades of scientific evidence on vaccine safety and efficacy.

Safety concerns raised over new Prader Willi syndrome drug

Experts raise concerns about potential safety risks, including patient deaths, associated with a newly approved drug for Prader Willi syndrome by Neurocrine Biosciences.

FDA Rejects Radiopharmaceutical Therapy Over Manufacturing Concerns

The FDA has declined approval for a promising radiopharmaceutical therapy, citing manufacturing concerns, delaying its competition with Novartis' treatment.

Radiopharmaceuticals face safety and regulatory hurdles despite cancer promise

Radiopharmaceuticals show promise as cancer treatments but face growing safety concerns and regulatory challenges that could slow progress.

Tenax Therapeutics heart failure drug fails in late stage trial

Tenax Therapeutics' experimental heart failure drug, Levosimendan, failed to meet primary endpoints in a late stage clinical trial, raising concerns about its efficacy.

WHO Pushes for Ebola Vaccine Trial Amid New Outbreak in Congo

The World Health Organization urges a clinical trial for the Ervebo vaccine in the Democratic Republic of Congo to curb a new Ebola outbreak caused by the Bundibugyo virus.